↓ Skip to main content

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Overview of attention for article published in Digestive Diseases and Sciences, December 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
1 X user
patent
3 patents
facebook
1 Facebook page
f1000
1 research highlight platform

Citations

dimensions_citation
251 Dimensions

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
Published in
Digestive Diseases and Sciences, December 2014
DOI 10.1007/s10620-014-3486-7
Pubmed ID
Authors

Maria Buti, Naoky Tsai, Joerg Petersen, Robert Flisiak, Selim Gurel, Zahary Krastev, Raul Aguilar Schall, John F. Flaherty, Eduardo B. Martins, Prista Charuworn, Kathryn M. Kitrinos, G. Mani Subramanian, Edward Gane, Patrick Marcellin

Abstract

Long-term tenofovir disoproxil fumarate (TDF) treatment for chronic hepatitis B (CHB) is associated with sustained viral suppression and regression of fibrosis and cirrhosis at year 5 (240 weeks) and no TDF resistance through 6 years (288 weeks).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 129 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 19%
Other 17 13%
Student > Master 17 13%
Student > Ph. D. Student 11 9%
Student > Bachelor 8 6%
Other 14 11%
Unknown 38 29%
Readers by discipline Count As %
Medicine and Dentistry 53 41%
Biochemistry, Genetics and Molecular Biology 12 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Agricultural and Biological Sciences 4 3%
Nursing and Health Professions 3 2%
Other 8 6%
Unknown 39 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2021.
All research outputs
#4,309,113
of 23,854,458 outputs
Outputs from Digestive Diseases and Sciences
#585
of 4,304 outputs
Outputs of similar age
#58,276
of 358,993 outputs
Outputs of similar age from Digestive Diseases and Sciences
#9
of 67 outputs
Altmetric has tracked 23,854,458 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,304 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.